News & Articles

Pre-clinical study finds evidence that Nuvec has the potential to deliver plasmids with anti-tumor effects in vivo

The Cytokine Release Syndrome (CRS) Evaluation Studies platform by The Jackson Laboratory (JAX) aims to predict toxic adverse effects of immunotherapy drugs

Discover the latest tools and techniques to expand your research capacity with expert-led presentations on cell therapy, cannabis potency testing, T-cell exhaustion, next generation sequencing, and more

Learn about the key considerations and challenges with developing cell-based assays that represent the functionality and safety of gene therapy products

Pregnant mothers’ environments influence brain development before birth

Data presented at the summit highlighted the potential of Janux’s TRACTr technology platform to support clinical development

Catch up on this expert-led discussion to explore how biomarkers are helping to drive early clinical phase trials, and more

Catch up on some of the most exciting advancements in clinical microbiology and infectious disease presented at ECCMID 2022

Findings suggest women with COVID-19 during pregnancy are five times more likely to be hospitalized, and six times as likely to require treatment in intensive care

Trial results presented at ECCMID show potential of Actiphage for risk stratification in those with latent TB

Blood test could be used to identify patients most likely to become severely ill before they deteriorate

The researchers were able to build a decision tree to predict COVID-19 patients at risk of a poor prognosis

Nursery children were found to be exposed to the greatest variety of pathogens and the highest concentrations compared to other groups investigated

An electronic questionnaire was used to gather information about sick leave and side effects from the 1,797 healthcare workers

SelectScience editors will be covering ECCMID 2022 so you can be sure not to miss out on top technology stories, product launches and latest research news from the event

In this article, you will find some of the pivotal research presented at the AACR annual meeting

Latinos are also more likely to be diagnosed with this cancer type

Study shows majority of pediatric cancer deaths are in lower- and middle-income countries

The RACE act has led to increased requirements for approval of recent pediatric cancer drugs

Discover the latest tools and techniques to support your laboratory workflows with expert-led presentations in cutting edge biopharmaceuticals research

Two-year follow up of the CodeBreaK100 clinical trial demonstrated prolonged tumor responses and a favorable safety profile

Researchers have found that a third COVID-19 vaccine increases vaccine effectiveness

SelectScience editors will be reporting the latest news from this year’s AACR annual meeting. Detailed here, are some of the key things to look out for